US-based clinical trial software company ProofPilot has partnered with non-profit organisation Digital Medicine Society (DiMe) to advance the development of digital tools for clinical research.
The partnership aims to gather data on physiological signals, mental health characteristics and behaviour traits in order to train a tool for preventing opioid use disorder relapse.
Go deeper with GlobalData
It will support DiMe’s efforts to progress the equitable and safe use of digital methods to enhance lives.
DiMe assistant programme director Candice Taguibao said: “We greatly appreciate the level of engagement and support from the entire ProofPilot team.
“Their dedication to advancing digital health aligns very well with our mission.
“We’re excited to work together to implement patient-centred approaches to clinical research and obtain insights to support the development of a digitally derived tool to help prevent relapse and reduce opioid use disorder deaths.”
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataBy using ProofPilot’s CoPilot platform, DiMe aims to improve trial experiences, simplify the collection of data, and offer digital solutions to trial sites and subjects.
ProofPilot said its Clinical Experience platform will give DiMe the necessary technology and tools to enhance trial accessibility.
This aligns with ProofPilot’s focus on developing digital health solutions that serve diverse patient populations and deliver measurable subject health impact.
ProofPilot CEO Chris Venezia said: “Partnering with DiMe aligns with our mission to improve clinical trials through digital innovation.
“Together, we’re bringing digital solutions to the forefront of clinical research, creating streamlined, patient-centred experiences and empowering all participants with advanced tools and support.”
DiMe serves as the professional home for digital medicine companies, handling challenges and developing clinical-quality resources.
ProofPilot claims to improve trials with its Clinical Experience Platform, which is designed to centralise and simplify communication for subjects, sites and sponsors throughout the trial experience.
Last year, the company began a strategic partnership with Verified Clinical Trials (VCT) with the aim to enhance participant integrity in study recruitment.
